02029
血液腫瘤科 | 醫師代碼:02029

張首義 癌症中心兼血液腫瘤科兼基因中心主任

  • 學歷
  • 經歷
  • 現職
  • 專長
  • 學會/資格/其他
  • 著作
  • 台灣大學醫學系
  • 台北慈濟醫院血腫科主治醫師暨腫瘤科主任
  • 和信醫院血腫科主治醫師
  • 和信醫院血腫科專研醫師
  • 和信醫院與台大醫院內科部住院醫師交叉訓練
  • 行天宮醫療志業醫療財團法人恩主公醫院-癌症中心-主任
  • 行天宮醫療志業醫療財團法人恩主公醫院-血液腫瘤科-主任
  • 行天宮醫療志業醫療財團法人恩主公醫院-基因中心-主任
  • 胃癌胰臟癌大腸直腸癌乳癌卵巢癌化學治療與標靶治療
  • 肺癌標靶治療免疫治療及化學治療
  • 惡性淋巴瘤診斷與治療
  • 治療胃癌胰臟癌卵巢癌腹膜轉移的腹膜化學治療
  • 肝癌末期肝動脈化療
  • 貧血診斷與治療
  • 血液疾病診斷與治療
  • 台灣內科醫學會內科專科醫師
  • 中華民國癌症醫學會腫瘤內科專科醫師
  • Peng TR, Wu CC, Chang SY, Chen YC, Wu TW, Hsu CS. Therapeutic efficacy of nivolumab plus sorafenib therapy in patients with unresectable hepatocellular carcinoma. Int Immunopharmacol. 2022 Sep 7;112:109223. doi: 10.1016/j.intimp.2022.109223. Epub ahead of print. PMID: 36084538. (IF 714, Rank: 59/162=36.41%)
  • Peng TR, Wu TW, Wu CC, Chang SY, Chan CY, Hsu CS. Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study. Tzu Chi Med J. 2021 Sep 10;34(2):219-225. doi: 10.4103/tcmj.tcmj_84_21. PMID: 35465280; PMCID: PMC9020249.
  • Wu CC, Tseng CW, Tseng KC, Chen YC, Wu TW, Chang SY, Chang YJ, Chao YC, Hsu CS. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan. J Formos Med Assoc. 2021 May;120(5):1249-1258. doi: 10.1016/j.jfma.2020.11.010. Epub 2020 Dec 4. PMID: 33288401. (SCI, IF 3.871, Rank: 61/172=35.46%)
  • Wang YN, Chang SY, Hwang JM, Chang YK, Kao WY, Wan HL, Tzeng IS, Wu CC. Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study. Tzu Chi Med J. 2021 Feb 22;33(3):288-293.
  • Lu LC, Tsay SL, Chang SY, Chen CM, Liu CY. Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis. Cancer Med. 2019;8(3):963-971. doi:10.1002/cam4.1976(IF 4.711, Rank: 106/245=43.26%)
  • Chang, S. Y., Kuo, C. C., Wu, C. C., Hsiao, C. W., Hu, J. M., Hsu, C. H., . . . Lin, Y. W. (2018). NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy. Genes Chromosomes Cancer, 57(5), 268-277. doi:10.1002/gcc.22529(IF 4.263, Rank: 64/175=36.5%)
  • Lu LC, Chang SY, Liu CY, Tsay SL. Reliability and validity of the Chinese version neuropathic pain symptom inventory in patients with colorectal cancer. J Formos Med Assoc. 2018;117(11):1019-1026. doi:10.1016/j.jfma.2017.11.010(IF: 871, Rank :61/172=35.46%)
  • Siew Tzuh Tang, DNSc; Tsang-Wu Liu, MD; Shou-Yi Chang, MD; and Ming-Chu Chiang, MS. A Decade of Changes in Preferences for Life-Sustaining Treatments Among Terminally Ill Patients With Cancer. J Natl Compr Canc Netw 2015;13:1510–1518.
  • 夏毅然, 許博智, 張首義, &黃經民. (2014). Spontaneous Fast-growing Osteosarcoma of the Maxilla Arising in Long-standing Polyostotic Fibrous Dysplasia-A Case Report. [長期罹患顱顏面多骨性纖維性發育不良導致上顎骨突然演變出生長快速的骨肉瘤形成-病例報告]. 臺灣口腔顎面外科學會雜誌, 25(3), 195-202.
  • 夏毅然, 許博智, 黃經民, 張首義, &余忠泰. (2013). Applying Induction Chemotherapy to Treat a Locoregionally Advanced Malignant Submandibular Gland Cancer-A Case Report. [合併使用誘導式化學療法來治療高度惡性且局部區域性淋巴結轉移的下顎下腺惡性腫瘤-病例報告]. 臺灣口腔顎面外科學會雜誌, 24(4), 253-264.
©2026行天宮醫療志業醫療財團法人恩主公醫院 En Chu Kong Hospital. All rights reserved. Web Design by FT